The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells - PubMed (original) (raw)
Review
The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells
A J McAdam et al. Immunol Rev. 1998 Oct.
Abstract
The functional significance of B7 co-stimulation in T-cell activation was described first in the context of preventing the induction of anergy. The functions of this pathway are far more complex than initially appreciated in view of the existence of two B7 molecules which have specificities for both CD28 and CTLA-4, which serve to amplify and terminate T-cell responses respectively. Mice lacking B7 co-stimulators and CD28 and CTLA-4 co-stimulatory receptors are helping to clarify the functions of this key immunoregulatory pathway. In this review we will focus on the role of B7 co-stimulation in the activation and differentiation of CD4+ helper cells and CD8+ cytotoxic cells. The contribution of B7 co-stimulation to CD4+ responses depends upon the activation history of the T-cell and the strength of the T-cell antigen receptor signal. B7 co-stimulation contributes to interleukin (IL)-2 production by both naive and previously activated CD4+ T cells. B7 co-stimulation is most critical for the differentiation of naive CD4+ T cells to IL-4 producers, but predominately influences IL-2 production by previously activated CD4+ cells. B7 co-stimulation is important in development of cytotoxic T cells through both effects on T-helper cells and by direct co-stimulation of CD8+ cells.
Similar articles
- The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y, Hiraoka S, Tomura M, Zhou XY, Yashiro-Ohtani Y, Mori Y, Shimizu J, Ono S, Dunussi-Joannopoulos K, Wolf S, Fujiwara H. Bian Y, et al. Int Immunol. 2005 Jan;17(1):73-83. doi: 10.1093/intimm/dxh188. Epub 2004 Nov 29. Int Immunol. 2005. PMID: 15569772 - B7-1-dependent co-stimulation results in qualitatively and quantitatively different responses by CD4+ and CD8+ T cells.
Deeths MJ, Mescher MF. Deeths MJ, et al. Eur J Immunol. 1997 Mar;27(3):598-608. doi: 10.1002/eji.1830270305. Eur J Immunol. 1997. PMID: 9079798 - CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro.
Levine BL, Ueda Y, Craighead N, Huang ML, June CH. Levine BL, et al. Int Immunol. 1995 Jun;7(6):891-904. doi: 10.1093/intimm/7.6.891. Int Immunol. 1995. PMID: 7577797 - Maturation of human neonatal CD4+ and CD8+ T lymphocytes into Th1/Th2 effectors.
Delespesse G, Yang LP, Ohshima Y, Demeure C, Shu U, Byun DG, Sarfati M. Delespesse G, et al. Vaccine. 1998 Aug-Sep;16(14-15):1415-9. doi: 10.1016/s0264-410x(98)00101-7. Vaccine. 1998. PMID: 9711781 Review. - CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model.
Van Gool SW, Vandenberghe P, de Boer M, Ceuppens JL. Van Gool SW, et al. Immunol Rev. 1996 Oct;153:47-83. doi: 10.1111/j.1600-065x.1996.tb00920.x. Immunol Rev. 1996. PMID: 9010719 Review.
Cited by
- New approach to generating of human monoclonal antibodies specific to the proteolytic domain of botulinum neurotoxin A.
Silkina MV, Kartseva AS, Riabko AK, Makarova MA, Rogozin MM, Romanenko YO, Shemyakin IG, Dyatlov IA, Firstova VV. Silkina MV, et al. Bioimpacts. 2024;14(4):27680. doi: 10.34172/bi.2023.27680. Epub 2023 Dec 30. Bioimpacts. 2024. PMID: 39104622 Free PMC article. - Tacrolimus treatment in women with repeated implantation failures.
Nakagawa K, Sugiyama R. Nakagawa K, et al. Reprod Med Biol. 2024 Jan 9;23(1):e12558. doi: 10.1002/rmb2.12558. eCollection 2024 Jan-Dec. Reprod Med Biol. 2024. PMID: 38196832 Free PMC article. Review. - Alcaligenes lipid A functions as a superior mucosal adjuvant to monophosphoryl lipid A via the recruitment and activation of CD11b+ dendritic cells in nasal tissue.
Sun X, Hosomi K, Shimoyama A, Yoshii K, Saika A, Yamaura H, Nagatake T, Kiyono H, Fukase K, Kunisawa J. Sun X, et al. Int Immunol. 2024 Jan 29;36(1):33-43. doi: 10.1093/intimm/dxad045. Int Immunol. 2024. PMID: 38006376 Free PMC article. - Pan-cancer analysis identifies PD-L2 as a tumor promotor in the tumor microenvironment.
Lv J, Jiang Z, Yuan J, Zhuang M, Guan X, Liu H, Yin Y, Ma Y, Liu Z, Wang H, Wang X. Lv J, et al. Front Immunol. 2023 Mar 16;14:1093716. doi: 10.3389/fimmu.2023.1093716. eCollection 2023. Front Immunol. 2023. PMID: 37006239 Free PMC article. - Identification of key genes involved in calcific aortic valve disease based on integrated bioinformatics analysis.
Liu YH, Liu Y, Xin YF, Zhang Q, Ding ML. Liu YH, et al. Exp Biol Med (Maywood). 2023 Jan;248(1):52-60. doi: 10.1177/15353702221118088. Epub 2022 Sep 23. Exp Biol Med (Maywood). 2023. PMID: 36151748 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials